Use of serum circulating CCNB2 in cancer surveillance

International Journal of Biological Markers

Volumn 25, Issue 4, 2010, Pages 236-242

  Mo, Min Li ^a   Chen, Zhao ^a   Li, Jie ^a   Li, Hai Long ^a   Sheng, Qing ^b   Ma, Hui Yan ^b   Zhang, Fang Xin ^c   Hua, Ya Wei ^d   Zhang, Xun ^e   Sun, Da Qiang ^e   Xu, Mei Lin ^e   Niu, Run Gui ^f   Xu, Jun Pu ^g   Zuo, Hui Jing ^g   Liu, Min ^g   Zhou, Hai Meng ^a  

^a TSINGHUA UNIVERSITY   (China)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

^c LANZHOU GENERAL HOSPITAL   (China)

^d Henan Cancer Hospital   (China)

^e TIANJIN CHEST HOSPITAL   (China)

^f SHANXI TUMOR HOSPITAL   (China)

^g Beijing ACCB Biotech Ltd   (China)

Author keywords

Cancer; Circulating RNA; Cyclin B2; Serum

Indexed keywords

CYCLIN B2; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLOOD LEVEL; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GENE EXPRESSION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CASE-CONTROL STUDIES; CYCLIN B2; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 78650816016     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2010.6088     Document Type: Article

References (20)

1. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 1995; 308 (Pt 3): 697-711.
2. Pines J. Four-dimensional control of the cell cycle. Nat Cell Biol 1999; 1: E73-9.
3. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36: 131-49.
4. Kumagai A, Dunphy WG. Control of the Cdc2/cyclin B complex in Xenopus egg extracts arrested at a G2/M checkpoint with DNA synthesis inhibitors. Mol Biol Cell 1995; 6: 199-213.
5. Sarafan-Vasseur N, Lamy A, Bourguignon J, et al. Overexpression of B-type cyclins alters chromosomal segregation. Oncogene 2002; 21: 2051-7.
6. Park S-H, Yu G-R, Kim W-H, Moon W-S, Kim J-H, Kim D-G. NF-Y-Dependent cyclin B2 expression in colorectal adenocarcinoma. Clin Cancer Res 2007; 13: 858-67.
7. Chapman DL, Wolgemuth DJ. Isolation of the murine cyclin B2 cDNA and characterization of the lineage and temporal specificity of expression of the B1 and B2 cyclins during oogenesis, spermatogenesis and early embryogenesis. Development 1993; 118: 229-40.
8. Draviam VM, Orrechia S, Lowe M, Pardi R, Pines J. The localization of human cyclins B1 and B2 determines CDK1 substrate specificity and neither enzyme requires MEK to disassemble the Golgi apparatus. J Cell Biol 2001; 152: 945-58.
9. Brandeis M, Rosewell I, Carrington M, et al. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc Natl Acad Sci U S A 1998; 95: 4344-9.
10. Stav D, Bar I, Sandbank J. Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma. Int J Biol Markers 2007; 22: 108-13.
11. Fernandez-Ranvier GG, Weng J, Yeh R-F, et al. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg 2008; 143: 841-6.
12. Johnson PJ, Lo YMD. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 2002; 48: 1186-93.
13. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids: a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 2007; 581: 795-9.
14. hPipinikas CP, Nair SB, Kirby RS, Carter ND, Fenske CD. Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers 2007; 12: 541-57.
15. Sheu CC, Chang MY, Chang HC, et al. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer. Oncology 2006; 70: 203-11.
16. Chen Z, Fan JQ, Li J, et al. Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer. Int J Cancer 2009; 124: 739-44.
17. Silva JM, Rodriguez R, Garcia JM, et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 2002; 50: 530-4.
18. Gahan PB, Swaminathan R. Circulating nucleic acids in plasma and serum: recent developments. Ann N Y Acad Sci 2008; 1137: 1-6. (Pubitemid 44532759)
19. El-Hefnawy T, Raja S, Kelly L, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004; 50: 564-73. (Pubitemid 38297307)
20. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, Languino LR. Alpha(v)beta3 integrin expression upregulates cdc2, which modulates cell migration. J Cell Biol 2003; 161: 817-26.